ACTIV-6 Study Making News

The ACTIV-6 study is making news! Here are links to some of the latest news reports featuring the ACTIV-6 study in Florida:

Spectrum News, Bay News 9, Tampa 

• USF, Tampa General Hospital join nationwide COVID treatment study

Fox 13 News, Tampa Bay

• COVID patients left with few treatment options after antibodies found ineffective against omicron
• Lakeland hospital taking part in COVID-19 Ivermectin study
• Lakeland patients part of ivermectin COVID-19 study

Tampa Bay Times

• USF, Tampa General study ivermectin, other drugs to treat COVID

ABC Action News/WFTS Tampa Bay

• TGH, USF Health part of study aimed at re-purposing medications to treat mild to moderate COVID-19:ACTIV‑6 study to look at ivermectin, fluticasone furoate, and fluvoxamine

Florida Politics

• Want ivermectin for COVID-19 treatment? UF Health study may be for you
• Tampa General to begin major clinical study on COVID-19 treatments

WFLA, News Channel 8, Tampa Bay (Lakeland)

• Lakeland Regional Health testing if Ivermectin really fights off COVID-19

The Ledger, Lakeland

• Lakeland Regional joins national study to see if ivermectin is effective against COVID-19

Orlando Sentinel, Orlando

• Lakeland hospital taking part in ivermectin study: report

Lakeland Gazette, Lakeland

• Lakeland Regional joins national study to see if ivermectin works against COVID-19

The Villages Daily Sun

• Residents join quest to find drugs that fight COVID-19

Florida Times Union

UF Health Jacksonville: COVID-19 trial studying effectiveness of ivermectin, 2 other drugs

Has your ACTIV-6 recruitment site recently received local news coverage? Please share the links with Brittney Roth (broth423@ufl.edu) or Diana Tonnessen (dtonn@ufl.edu).

For a customizable copy of the OneFlorida ACTIV-6 news release, please contact OneFlorida+ Communications Manager Diana Tonnessen, dtonn@ufl.edu or 352-294-5972.